Purchase Order 75N91021P00843

Award Date 9/15/21
Potential Completion Date 1/31/24
Potential Value $180K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30322, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
8
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Emory University, a private research institution in Atlanta, Georgia. The contract is for a "Patterns of Care/Quality of Care Study: Diagnosis Year 2016" and has a ceiling value of $53,572. The contract is Firm Fixed Price and is not set aside for any specific business type. Emory University, through its Office of Sponsored Programs Division,...
The National Cancer Institute (NCI) has awarded a $248,767 firm fixed-price purchase order contract to Proton Doctors Professional Corporation for the US Pediatric Proton and Photon Therapy Cohort, a retrospective cohort study comparing risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. This contract is not set-aside. The goal is to obtain de-identified clinical and treatment data from existing medical records of eligible pediatric patients treated with...
This federal contract award is for a "Patterns of Care/Quality of Care Study (POC): Diagnosis Year 2015" project, awarded by the National Cancer Institute (NCI) to Emory University. The period of performance is from August 15, 2016 to August 14, 2017, with a ceiling value of $54,377. The contract is a Delivery Order under the Firm Fixed Price pricing type. Emory University, a private research institution in Atlanta, Georgia, is the prime contractor for this award. The contract is...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm-fixed-price purchase order contract to The Ohio State University to obtain data on a group of proton-treated pediatric cancer patients and a comparison group of photon-treated pediatric cancer patients. The $243,347.00 contract has a completion date of September 14, 2023. The Ohio State University, a public research university, will retrieve existing medical record data on...
This is a $138,343.00 firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Emory University, a private research university in Atlanta, Georgia. The contract is part of the Surveillance Epidemiology and End Results (SEER) Patterns of Care (POC)/Quality of Care Study for diagnosis year 2019, focusing on urinary bladder cancer and kidney cancer. Emory University, through its Office of Sponsored Programs Division, is the prime contractor for this study. The...
The National Cancer Institute (NCI) has awarded a $249,814 firm-fixed-price purchase order contract to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, for the US Pediatric Proton and Photon Therapy Cohort study. This retrospective cohort study aims to compare the risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. The contractor will retrieve de-identified clinical and treatment data...
The National Cancer Institute (NCI) awarded a $250,000 firm fixed-price purchase order to Baylor College of Medicine to establish the U.S. Pediatric Proton and Photon Therapy Cohort, a retrospective study comparing risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. The contractor will retrieve de-identified clinical and treatment data from existing medical records of eligible pediatric patients treated at their institution with proton or photon therapy....
This federal contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Emory University, a private research institution in Atlanta, Georgia. The $47,137 Firm Fixed Price contract is for the Surveillance, Epidemiology, and End Results (SEER) Program Patterns of Care/Quality of Care Study (POC) for diagnosis year 2014. The contract does not have a set-aside designation. Emory University, through its Office of Sponsored Programs Division, is...
Emory University was awarded a $249,215.40 firm fixed price purchase order by the National Cancer Institute, part of the Department of Health and Human Services, to conduct a study investigating exposure to perfluorooctanoic acid (PFOA) and mutational signatures in clear cell renal cell carcinoma. The study will involve analyzing plasma samples from 1,330 subjects, including 1,085 renal cancer cases and 245 healthy controls, to assess the association between PFOA and other per- and...
This is a firm-fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research university in Atlanta, Georgia. The contract, valued at $3,000.00, is for cancer and HIV research work to be completed by September 29, 2024. The contract is not set aside for any specific socioeconomic category. Emory University is a major recipient of federal research funding and has extensive capabilities across medical and scientific...

Emory University was awarded a $180,030 firm fixed-price purchase order contract by the National Cancer Institute, part of the U.S. Department of Health and Human Services, to obtain data on a group of proton-treated pediatric cancer patients and a comparison group of photon-treated pediatric cancer patients. The contract is part of the US Pediatric Proton/Photon Therapy Cohort Study major program, with a completion date of January 31, 2024. No set-aside was used for this award.

Generated 3/23/24, 5:53 PM